William M. Sullivan, a director of Privia Health Group, Inc. (NASDAQ: PRVA), sold 12,115 shares of the company’s stock on Friday, December 23. Because of the sale of the shares, the overall value of the transaction came to a total of $283,369.85, which is equivalent to a price of $23.39 for each share on average. Following the completion of the acquisition, the director now has a total of 5,845,083 shares of the company’s stock, which are currently valued at a sum equal to or greater than $136,716,491.37. When you click on this link, you will be taken to a document given to the SEC. This document contains information about the transaction and the presentation given to the SEC.
Privia Health Group (NASDAQ: PRVA) announced the outcomes of its most recent quarterly financial report on Thursday, November 10. During that period, the company had a profit of $0.01 for each share it issued. However, the return on equity for Privia Health Group was also negative, coming in at 6.82%, and the net margin for the company was also negative, coming in at 3.02%. Both of these figures represent a loss for the business. According to the analysts’ projections, the anticipated revenue for the next fiscal quarter could fall from $323.66 million to $342.90 million. The projections of those knowledgeable in this field indicate that Privia Health Group, Inc. will lose 0.26 cents per share throughout the current fiscal year.
Several brokerage firms have published research on PRVA on their respective websites within the past few months. Piper Sandler disclosed their new price objective for Privia Health Group shares to be $42.00 in a research note that was made public on November 17. Piper Sandler’s announcement can be found here. On December 8, Stifel Nicolaus began researching Privia Health Group, and on that same day, a report detailing their findings was made public for the first time. They recommended that investors “buy” the stock and set its price objective at $28.00. In a report made public on Friday, November 11, Canaccord Genuity Group stated that their price target for Privia Health Group had decreased from $50.00 to $43.00. The report was about the price target reduction. In a research note published on Friday, November 11, SVB Leerink lowered their price target on Privia Health Group from $46.00 to $39.00 and lowered the “outperform” rating they had previously assigned to the company. Truist Financial lowered its price target for Privia Health Group in a report published on November 17, bringing it to $41.00. The final and most significant adjustment was made here. There are thirteen different investment analysts who all recommend that a buyer purchase the stock in question. According to the data that Bloomberg provided, the company is currently receiving an average recommendation of “Buy,” and its price target is projected to be $39.36 on average.
The price of NASDAQ PRVA fell by $0.22 during trading on Tuesday, bringing it down to $23.18 from its previous level. The company’s stock was traded 354,241 times, significantly less than the typical volume of 829,906 shares. The moving average of the company’s stock price over the past 200 days is $32.17, while the moving average over the past 50 days is $26.72. Privia Health Group, Inc. reached a low point over the past 52 weeks of $17.99, while the company reached a high point over the past 52 weeks of $44.64. The stock currently trades at a market value of $2.65 billion and carries a price-to-earnings ratio of -63.44. It has a beta value of 0.66.
Over the past few months, several hedge funds have been active buyers and sellers of PRVA stock. As a result, the value of Assetmark Inc.’s holdings in Privia Health Group increased by 119.4% over the second quarter. Because the company purchased an additional 486 shares during the most recent quarter, Assetmark Inc. now has a total of 893 shares of its stock, which are currently valued at $26,000 and give the company a market capitalization of First Horizon Advisors Inc. increased the proportion of Privia Health Group stock that is owned by 4,330.4 percent during the second quarter of the year. During the most recent quarter, First Horizon Advisors Inc. increased the number of shares it owns in the company by 996. This brought the total number of shares it owns in the company to 1,019, with an associated value of $29,000. During the third quarter, Signaturefd LLC spent approximately $32,000 to acquire a further stake in Privia Health Group. In addition, Nisa Investment Advisors LLC incurred additional expenses amounting to $46,000 in the second quarter of the fiscal year when it decided to make a new investment in Privia Health Group.
Last but not least, during the first quarter of the fiscal year, Point72 Hong Kong Ltd. acquired a new holding in Privia Health Group shares, which resulted in an increase of approximately $47,000 in the company’s revenue. Institutional investors and hedge funds own 66.83 percent of the company’s shares. Other shareholders include private individuals.
It is common knowledge that Privia Health Group, Inc. is the leading provider of physician support services across the entirety of the United States. The company collaborates with medical organizations, insurance companies, and healthcare systems to enhance patient care, streamline physician workflows, and provide financial compensation to medical professionals who treat patients both in-person and remotely.
Source: news.google.com
